Skip to main content
Clinical Trials/NCT00421265
NCT00421265
Unknown
N/A

Prospective Cohort Study of Active Surveillance for Prostate Cancer With Indolent Linical Features

Assaf-Harofeh Medical Center1 site in 1 country150 target enrollmentJanuary 11, 2007
ConditionsProstate Cancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Prostate Cancer
Sponsor
Assaf-Harofeh Medical Center
Enrollment
150
Locations
1
Last Updated
19 years ago

Overview

Brief Summary

In patients with prostate cancer with indolent features, disease progrssion may be very slow and in many cases will never become clinically evident during the patient's lifetime. Active surveillance is a continuous process of monitoring disease characteristcs aiming to avoid the morbidity of active therapy in patients with stabe indolent parameters, while offering early detection of disease activity in others who will need active therapy to control their disease. We hypothesize that active surveillance will permit the avoidance of therapy related morbidity in the majority of appropriate patients and will be associated with maintaining their quality of life.

Registry
clinicaltrials.gov
Start Date
January 11, 2007
End Date
TBD
Last Updated
19 years ago
Study Type
Observational
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Men 65 years of age or older who were diagnosed with prostate cancer in the past 3 month prior to inclusion
  • Gleason's score of 6 or less.
  • Clinical T1C per digital rectal exam.
  • Pre biopsy PSA serum level of 6.0ng/ml or less.
  • The presence of cancer in a single biopsy core of at least 8 taken.
  • The presence of cancer in no more than 10% of the length of the core involved.
  • Patient's consent to engage in active surveillance after being informed of the benefits and potential risks of this approach as well as of alternative lines of therapy.
  • Israeli residence with the readiness to be available for the followup schedule.

Exclusion Criteria

  • Patients who do not meet the above eligibility criteria

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials